Search

Author/Creator Aggrey, Angela

1. 1339. Results for the Supplemental Microbiological Modified Intent-to-Treat (SmMITT) Population of the RESTORE-IMI 1 Trial of Imipenem/Cilastatin/Relebactam (IMI/REL) vs. Imipenem/Cilastatin Plus Colistin (IMI+CST) in Patients with Imipenem-Nonsusceptible (NS) Bacterial Infections. (26th November 2018)

Authors:
Kaye, Keith; File, Thomas; Boucher, Helen W; Brown, Michelle; Aggrey, Angela; Khan, Ireen; Joeng, Hee-Koung; Tipping, Robert; Du, Jiejun; Young, Katherine; Butterton, Joan; Kartsonis, Nicholas A; Paschke, Amanda
Journal:
Open forum infectious diseases
Issue:
Volume 5(2018)Supplement 1
Page Start:
S409
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 1951. Nephrotoxicity Associated With Imipenem/Cilastatin/Relebactam (IMI/REL) vs. Imipenem/Cilastatin Plus Colistin (IMI+CST) in Patients With Imipenem-Nonsusceptible (NS) Bacterial Infections. (26th November 2018)

Authors:
Brown, Michelle; Motsch, Johann; Kaye, Keith; File, Thomas; Boucher, Helen W; Vendetti, Neika; Aggrey, Angela; Joeng, Hee-Koung; Tipping, Robert; Du, Jiejun; Depestel, Daryl D; Butterton, Joan; Kartsonis, Nicholas A; Paschke, Amanda
Journal:
Open forum infectious diseases
Issue:
Volume 5(2018)Supplement 1
Page Start:
S563
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 Study. (19th February 2020)

Authors:
Brown, Michelle L; Motsch, Johann; Kaye, Keith S; File, Thomas M; Boucher, Helen W; Vendetti, Neika; Aggrey, Angela; Joeng, Hee-Koung; Tipping, Robert W; Du, Jiejun; DePestel, Daryl D; Butterton, Joan R; Paschke, Amanda
Journal:
Open forum infectious diseases
Issue:
Volume 7:Number 3(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections. (10th August 2019)

Authors:
Motsch, Johann; Murta de Oliveira, Cláudia; Stus, Viktor; Köksal, Iftihar; Lyulko, Olexiy; Boucher, Helen W; Kaye, Keith S; File, Thomas M; Brown, Michelle L; Khan, Ireen; Du, Jiejun; Joeng, Hee-Koung; Tipping, Robert W; Aggrey, Angela; Young, Katherine; Kartsonis, Nicholas A; Butterton, Joan R; ...
Journal:
Clinical infectious diseases
Issue:
Volume 70:Number 9(2020)
Page Start:
1799
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗